The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Exosome Rapid Molecular Detection Market Research Report 2025

Global Exosome Rapid Molecular Detection Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1910005

No of Pages : 103

Ask Your Query
Synopsis
Exosome molecular detection refers to methods and technologies used to identify, isolate, and analyze exosomes at the molecular level.
The global Exosome Rapid Molecular Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Exosome Rapid Molecular Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosome Rapid Molecular Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Exosome Rapid Molecular Detection in Cancers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Exosome Rapid Molecular Detection include Thermo Fisher Scientific, Bio-Techne, System Biosciences, QIAGEN, Lonza, NX Pharmagen, NanoSomiX, Miltenyi Biotech and Norgen Biotek, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Rapid Molecular Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Rapid Molecular Detection.
Report Scope
The Exosome Rapid Molecular Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Rapid Molecular Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Rapid Molecular Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Techne
System Biosciences
QIAGEN
Lonza
NX Pharmagen
NanoSomiX
Miltenyi Biotech
Norgen Biotek
AMSBio
Aethlon Medical
Anjarium Biosciences
Ciloa
InnovaPrep
Creative Medical Technologies
ILIAS Biologics
Unchained Labs
Rion
Cell Guidance System
INOVIQ
Danaher
Exopharm
Everzom
RoosterBio
Creative Biolabs
Segment by Type
Kits & Reagents
Instruments
Services
Segment by Application
Cancers
Neurodegenerative Diseases
Cardiovascular Diseases
Infectious Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Rapid Molecular Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Rapid Molecular Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kits & Reagents
1.2.3 Instruments
1.2.4 Services
1.3 Market by Application
1.3.1 Global Exosome Rapid Molecular Detection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancers
1.3.3 Neurodegenerative Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Rapid Molecular Detection Market Perspective (2019-2030)
2.2 Exosome Rapid Molecular Detection Growth Trends by Region
2.2.1 Global Exosome Rapid Molecular Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Rapid Molecular Detection Historic Market Size by Region (2019-2024)
2.2.3 Exosome Rapid Molecular Detection Forecasted Market Size by Region (2025-2030)
2.3 Exosome Rapid Molecular Detection Market Dynamics
2.3.1 Exosome Rapid Molecular Detection Industry Trends
2.3.2 Exosome Rapid Molecular Detection Market Drivers
2.3.3 Exosome Rapid Molecular Detection Market Challenges
2.3.4 Exosome Rapid Molecular Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Rapid Molecular Detection Players by Revenue
3.1.1 Global Top Exosome Rapid Molecular Detection Players by Revenue (2019-2024)
3.1.2 Global Exosome Rapid Molecular Detection Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Rapid Molecular Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Rapid Molecular Detection Revenue
3.4 Global Exosome Rapid Molecular Detection Market Concentration Ratio
3.4.1 Global Exosome Rapid Molecular Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Rapid Molecular Detection Revenue in 2023
3.5 Exosome Rapid Molecular Detection Key Players Head office and Area Served
3.6 Key Players Exosome Rapid Molecular Detection Product Solution and Service
3.7 Date of Enter into Exosome Rapid Molecular Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Rapid Molecular Detection Breakdown Data by Type
4.1 Global Exosome Rapid Molecular Detection Historic Market Size by Type (2019-2024)
4.2 Global Exosome Rapid Molecular Detection Forecasted Market Size by Type (2025-2030)
5 Exosome Rapid Molecular Detection Breakdown Data by Application
5.1 Global Exosome Rapid Molecular Detection Historic Market Size by Application (2019-2024)
5.2 Global Exosome Rapid Molecular Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Rapid Molecular Detection Market Size (2019-2030)
6.2 North America Exosome Rapid Molecular Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
6.4 North America Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Rapid Molecular Detection Market Size (2019-2030)
7.2 Europe Exosome Rapid Molecular Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
7.4 Europe Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Rapid Molecular Detection Market Size (2019-2030)
8.2 Asia-Pacific Exosome Rapid Molecular Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exosome Rapid Molecular Detection Market Size by Region (2019-2024)
8.4 Asia-Pacific Exosome Rapid Molecular Detection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Rapid Molecular Detection Market Size (2019-2030)
9.2 Latin America Exosome Rapid Molecular Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
9.4 Latin America Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Rapid Molecular Detection Market Size (2019-2030)
10.2 Middle East & Africa Exosome Rapid Molecular Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
10.4 Middle East & Africa Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Exosome Rapid Molecular Detection Introduction
11.1.4 Thermo Fisher Scientific Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Detail
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Exosome Rapid Molecular Detection Introduction
11.2.4 Bio-Techne Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.2.5 Bio-Techne Recent Development
11.3 System Biosciences
11.3.1 System Biosciences Company Detail
11.3.2 System Biosciences Business Overview
11.3.3 System Biosciences Exosome Rapid Molecular Detection Introduction
11.3.4 System Biosciences Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.3.5 System Biosciences Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Detail
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Exosome Rapid Molecular Detection Introduction
11.4.4 QIAGEN Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.4.5 QIAGEN Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Exosome Rapid Molecular Detection Introduction
11.5.4 Lonza Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.5.5 Lonza Recent Development
11.6 NX Pharmagen
11.6.1 NX Pharmagen Company Detail
11.6.2 NX Pharmagen Business Overview
11.6.3 NX Pharmagen Exosome Rapid Molecular Detection Introduction
11.6.4 NX Pharmagen Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.6.5 NX Pharmagen Recent Development
11.7 NanoSomiX
11.7.1 NanoSomiX Company Detail
11.7.2 NanoSomiX Business Overview
11.7.3 NanoSomiX Exosome Rapid Molecular Detection Introduction
11.7.4 NanoSomiX Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.7.5 NanoSomiX Recent Development
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Detail
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Exosome Rapid Molecular Detection Introduction
11.8.4 Miltenyi Biotech Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.8.5 Miltenyi Biotech Recent Development
11.9 Norgen Biotek
11.9.1 Norgen Biotek Company Detail
11.9.2 Norgen Biotek Business Overview
11.9.3 Norgen Biotek Exosome Rapid Molecular Detection Introduction
11.9.4 Norgen Biotek Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.9.5 Norgen Biotek Recent Development
11.10 AMSBio
11.10.1 AMSBio Company Detail
11.10.2 AMSBio Business Overview
11.10.3 AMSBio Exosome Rapid Molecular Detection Introduction
11.10.4 AMSBio Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.10.5 AMSBio Recent Development
11.11 Aethlon Medical
11.11.1 Aethlon Medical Company Detail
11.11.2 Aethlon Medical Business Overview
11.11.3 Aethlon Medical Exosome Rapid Molecular Detection Introduction
11.11.4 Aethlon Medical Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.11.5 Aethlon Medical Recent Development
11.12 Anjarium Biosciences
11.12.1 Anjarium Biosciences Company Detail
11.12.2 Anjarium Biosciences Business Overview
11.12.3 Anjarium Biosciences Exosome Rapid Molecular Detection Introduction
11.12.4 Anjarium Biosciences Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.12.5 Anjarium Biosciences Recent Development
11.13 Ciloa
11.13.1 Ciloa Company Detail
11.13.2 Ciloa Business Overview
11.13.3 Ciloa Exosome Rapid Molecular Detection Introduction
11.13.4 Ciloa Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.13.5 Ciloa Recent Development
11.14 InnovaPrep
11.14.1 InnovaPrep Company Detail
11.14.2 InnovaPrep Business Overview
11.14.3 InnovaPrep Exosome Rapid Molecular Detection Introduction
11.14.4 InnovaPrep Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.14.5 InnovaPrep Recent Development
11.15 Creative Medical Technologies
11.15.1 Creative Medical Technologies Company Detail
11.15.2 Creative Medical Technologies Business Overview
11.15.3 Creative Medical Technologies Exosome Rapid Molecular Detection Introduction
11.15.4 Creative Medical Technologies Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.15.5 Creative Medical Technologies Recent Development
11.16 ILIAS Biologics
11.16.1 ILIAS Biologics Company Detail
11.16.2 ILIAS Biologics Business Overview
11.16.3 ILIAS Biologics Exosome Rapid Molecular Detection Introduction
11.16.4 ILIAS Biologics Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.16.5 ILIAS Biologics Recent Development
11.17 Unchained Labs
11.17.1 Unchained Labs Company Detail
11.17.2 Unchained Labs Business Overview
11.17.3 Unchained Labs Exosome Rapid Molecular Detection Introduction
11.17.4 Unchained Labs Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.17.5 Unchained Labs Recent Development
11.18 Rion
11.18.1 Rion Company Detail
11.18.2 Rion Business Overview
11.18.3 Rion Exosome Rapid Molecular Detection Introduction
11.18.4 Rion Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.18.5 Rion Recent Development
11.19 Cell Guidance System
11.19.1 Cell Guidance System Company Detail
11.19.2 Cell Guidance System Business Overview
11.19.3 Cell Guidance System Exosome Rapid Molecular Detection Introduction
11.19.4 Cell Guidance System Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.19.5 Cell Guidance System Recent Development
11.20 INOVIQ
11.20.1 INOVIQ Company Detail
11.20.2 INOVIQ Business Overview
11.20.3 INOVIQ Exosome Rapid Molecular Detection Introduction
11.20.4 INOVIQ Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.20.5 INOVIQ Recent Development
11.21 Danaher
11.21.1 Danaher Company Detail
11.21.2 Danaher Business Overview
11.21.3 Danaher Exosome Rapid Molecular Detection Introduction
11.21.4 Danaher Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.21.5 Danaher Recent Development
11.22 Exopharm
11.22.1 Exopharm Company Detail
11.22.2 Exopharm Business Overview
11.22.3 Exopharm Exosome Rapid Molecular Detection Introduction
11.22.4 Exopharm Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.22.5 Exopharm Recent Development
11.23 Everzom
11.23.1 Everzom Company Detail
11.23.2 Everzom Business Overview
11.23.3 Everzom Exosome Rapid Molecular Detection Introduction
11.23.4 Everzom Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.23.5 Everzom Recent Development
11.24 RoosterBio
11.24.1 RoosterBio Company Detail
11.24.2 RoosterBio Business Overview
11.24.3 RoosterBio Exosome Rapid Molecular Detection Introduction
11.24.4 RoosterBio Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.24.5 RoosterBio Recent Development
11.25 Creative Biolabs
11.25.1 Creative Biolabs Company Detail
11.25.2 Creative Biolabs Business Overview
11.25.3 Creative Biolabs Exosome Rapid Molecular Detection Introduction
11.25.4 Creative Biolabs Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.25.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock